NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health announced a quarterly dividend on Wednesday, May 9th. Stockholders of record on Monday, July 2nd will be given a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 dividend on an annualized basis and a dividend yield of 3.90%. The ex-dividend date is Friday, June 29th. This is an increase from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health announced that its Board of Directors has initiated a share buyback program on Thursday, February 8th 2018, which authorizes the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's leadership believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) announced its earnings results on Thursday, May, 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.51 by $0.12. The company had revenue of $33.63 billion for the quarter, compared to analyst estimates of $33.61 billion. Cardinal Health had a net margin of 1.26% and a return on equity of 23.39%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.42.

15 Wall Street analysts have issued 12 month target prices for Cardinal Health's shares. Their predictions range from $40.00 to $81.00. On average, they expect Cardinal Health's stock price to reach $64.8571 in the next year. This suggests a possible upside of 32.9% from the stock's current price. View Analyst Ratings for Cardinal Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

News headlines about CAH stock have been trending somewhat positive this week, according to Accern. The research group scores the sentiment of press coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cardinal Health earned a news sentiment score of 0.08 on Accern's scale. They also gave news stories about the company an impact score of 44.95 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

Cardinal Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Hexavest Inc. (0.30%), Deprince Race & Zollo Inc. (0.14%), Bank of Montreal Can (0.09%), Howard Capital Management Inc. (0.07%), Retirement Systems of Alabama (0.05%) and Denali Advisors LLC (0.04%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hexavest Inc., Hartford Investment Management Co., Huntington National Bank, Nippon Life Global Investors Americas Inc., Retirement Systems of Alabama, Nisa Investment Advisors LLC and Riverbridge Partners LLC. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was bought by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Howard Capital Management Inc., Deprince Race & Zollo Inc., Whittier Trust Co., Cornerstone Wealth Management LLC, State of Alaska Department of Revenue, Regent Investment Management LLC and Kempner Capital Management Inc.. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $48.80.

Cardinal Health has a market capitalization of $15.22 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]